Chenggang Li
11PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jun 26, 2024
MCL restrained ROS/AKT/ASAH1 pathway to therapy tamoxifen resistance breast cancer by stabilizing NRF2.Xiao Han, Yupeng Zhang, Yin Li
|Jul 21, 2023
Glutaredoxin-1 promotes lymphangioleiomyomatosis progression through inhibiting Bim-mediated apoptosis via COX2/PGE2/ERK pathway.Ya Feng, Tianjiao Li, Yin Li
|May 26, 2023
G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression.Yin Li, Xiao Han, Zhoujun Lin
|Feb 22, 2023
Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma.Ya Feng, Tianjiao Li, Zhoujun Lin
|Dec 22, 2022
The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma.Juan Yang, Yin Li, Xiao Han
|Dec 21, 2022
Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM).Fei Li, Yifan Zhang, Zhoujun Lin
Pageof 2
